Private equity in healthcare has exploded, and investors looking to get into the healthcare PE action face several challenges to get to expected returns. In this episode of the JTaylor Healthcare Podcast, Arielle Schmeck, CPA/ABV, CM&AA joins Kyle and Herd to discuss the impact of healthcare PE, changes in investor approach, and the rise in scrutiny. Arielle also shares insights from her article, "Private Equity and Health Care Investments: How Has COVID-19 Impacted Deal Flow?" which covers the healthcare PE deal flow funnel as a result of the pandemic, access to cheap debt, and excess "dry powder".

Private Equity and Health Care Investments: How Has COVID-19 Impacted Deal Flow?
https://www.jtaylor.com/news/private-equity-and-health-care-investments-how-has-covid-19-impacted-deal-flow